In a recent article published by the Brownstone Institute, Dr. David Gortler sheds light on the lack of transparency and oversight in the testing and manufacturing of mRNA injections for Covid. As Americans, we are fully dependent on the FDA and vaccine manufacturers to ensure the purity and consistency of these injections. However, the testing methodologies and results have become confidential, raising concerns about the safety and efficacy of these vaccines.
One of the major issues highlighted in the article is the secrecy surrounding the testing methodologies used by manufacturers and the FDA. The public has no access to information about potential contamination or variability in the mRNA sequence or its lipid nanoparticle components. This lack of transparency is especially troubling considering that vaccine manufacturers have received billions of dollars in taxpayer funds for their research and development efforts. The article questions whether it is appropriate to label ingredient information as proprietary/trade secret when it was funded by taxpayer dollars.
Additionally, both the Trump and Biden administrations have proposed lifting intellectual property rights for mRNA injections. However, ingredient information is still tightly protected as proprietary/trade secret, preventing independent scientists from accessing vital information to confirm the safety and consistency of these vaccines.
The article emphasizes the importance of a transparent and publicly accountable FDA that should prospectively test regulated products for qualitative and quantitative consistency, making the findings publicly available. It also calls for sharing the testing methodology for mRNA Covid products with scientists who wish to confirm the results. However, attempts to access this information have been met with redactions and embargoed reports, hindering independent verification.
The lack of ingredient transparency is another concern raised in the article. Unlike other FDA-approved pharmaceuticals, Covid mRNA injections do not provide the sequence, molecular weight, and milligram strength on their official FDA package labels. This deviation from standard labeling practices raises questions about the accuracy and completeness of information provided to the public.
Furthermore, the FDA's decision to monitor pharmaceutical quality through a remote collection of “mailed-in” drug samples is criticized in the article. This method is deemed unreliable and inadequate, akin to monitoring restaurants by asking them to periodically mail in food samples for testing.
The article concludes by emphasizing the need for ingredient transparency and improved quality control oversight in the manufacturing of pharmaceuticals. The FDA's mission, established in 1906, was to provide ingredient transparency and assure quality. Americans deserve complete transparency and confidence in the safety and efficacy of the medications they are prescribed, especially during a public health crisis like Covid.
In summary, Dr. Gortler's article highlights the lack of transparency and oversight in the testing and manufacturing of mRNA injections for Covid. The confidential testing methodologies, proprietary ingredient information, and inadequate sampling methods raise concerns about the safety and consistency of these vaccines. The article calls for a transparent and accountable FDA that provides ingredient transparency, shares testing methodologies, and ensures rigorous quality control measures. It advocates for complete transparency and improved oversight to safeguard the health of Americans.
